BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Schenk, Kuipers, Klinkenberg-knol, Bloemena, Nelis, Festen, Jansen, Biemond, Lamers, Meuwissen. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection: HYPERGASTRINAEMIA WITH LONG-TERM OMEPRAZOLE. Alimentary Pharmacology & Therapeutics 1998;12:605-12. [DOI: 10.1046/j.1365-2036.1998.00349.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 DeVault KR. Overview of medical therapy for gastroesophageal reflux disease. Gastroenterol Clin North Am. 1999;28:831-845. [PMID: 10695004 DOI: 10.1016/s0889-8553(05)70092-3] [Cited by in Crossref: 23] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
2 Scaillon M, Cadranel S. Safety Data Required for Proton-Pump Inhibitor Use in Children: . Journal of Pediatric Gastroenterology and Nutrition 2002;35:113-8. [DOI: 10.1097/00005176-200208000-00004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
3 Kuipers EJ. Proton pump inhibitors and gastric neoplasia. Gut 2006;55:1217-21. [PMID: 16905689 DOI: 10.1136/gut.2005.090514] [Cited by in Crossref: 68] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
4 Basuroy R, Srirajaskanthan R, Prachalias A, Quaglia A, Ramage JK. Review article: the investigation and management of gastric neuroendocrine tumours. Aliment Pharmacol Ther. 2014;39:1071-1084. [PMID: 24628514 DOI: 10.1111/apt.12698] [Cited by in Crossref: 59] [Cited by in F6Publishing: 55] [Article Influence: 7.4] [Reference Citation Analysis]
5 Tran-duy A, Spaetgens B, Hoes AW, de Wit NJ, Stehouwer CD. Use of Proton Pump Inhibitors and Risks of Fundic Gland Polyps and Gastric Cancer: Systematic Review and Meta-analysis. Clinical Gastroenterology and Hepatology 2016;14:1706-1719.e5. [DOI: 10.1016/j.cgh.2016.05.018] [Cited by in Crossref: 88] [Cited by in F6Publishing: 78] [Article Influence: 14.7] [Reference Citation Analysis]
6 Huang XQ. Helicobacter pylori infection and gastrointestinal hormones: A review. World J Gastroenterol 2000; 6(6): 783-788 [PMID: 11819696 DOI: 10.3748/wjg.v6.i6.783] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.4] [Reference Citation Analysis]
7 Cavalcoli F, Zilli A, Conte D, Ciafardini C, Massironi S. Gastric neuroendocrine neoplasms and proton pump inhibitors: fact or coincidence? Scand J Gastroenterol. 2015;50:1397-1403. [PMID: 26059834 DOI: 10.3109/00365521.2015.1054426] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 3.6] [Reference Citation Analysis]
8 Jana K, Chandar NB, Bandyopadhyay T, Ganguly B. Role of Noncovalent Interactions in Designing Inhibitors for H + ,K + -ATPase: Combined QM and MD Based Investigations. ChemistrySelect 2016;1:6847-54. [DOI: 10.1002/slct.201601458] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
9 Thomson AB, Sauve MD, Kassam N, Kamitakahara H. Safety of the long-term use of proton pump inhibitors. World J Gastroenterol 2010; 16(19): 2323-2330 [PMID: 20480516 DOI: 10.3748/wjg.v16.i19.2323] [Cited by in CrossRef: 167] [Cited by in F6Publishing: 132] [Article Influence: 13.9] [Reference Citation Analysis]
10 Graham DY, Genta RM. Long-term proton pump inhibitor use and gastrointestinal cancer. Curr Gastroenterol Rep 2008;10:543-7. [PMID: 19006608 DOI: 10.1007/s11894-008-0100-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 2.9] [Reference Citation Analysis]
11 Song H, Zhu J, Lu D. Long-term proton pump inhibitor (PPI) use and the development of gastric pre-malignant lesions. Cochrane Database Syst Rev. 2014;CD010623. [PMID: 25464111 DOI: 10.1002/14651858.cd010623.pub2] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
12 Ellis L, Shale MJ, Coleman MP. Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol. 2010;105:2563-2569. [PMID: 20823835 DOI: 10.1038/ajg.2010.341] [Cited by in Crossref: 149] [Cited by in F6Publishing: 136] [Article Influence: 12.4] [Reference Citation Analysis]
13 Jensen RT. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas. Basic Clin Pharmacol Toxicol. 2006;98:4-19. [PMID: 16433886 DOI: 10.1111/j.1742-7843.2006.pto_378.x] [Cited by in Crossref: 90] [Cited by in F6Publishing: 76] [Article Influence: 5.6] [Reference Citation Analysis]
14 Jana K, Bandyopadhyay T, Ganguly B. Designed inhibitors with hetero linkers for gastric proton pump H+,K+-ATPase: Steered molecular dynamics and metadynamics studies. J Mol Graph Model 2017;78:129-38. [PMID: 29055186 DOI: 10.1016/j.jmgm.2017.10.006] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
15 Waldum HL, Gustafsson B, Fossmark R, Qvigstad G. Antiulcer drugs and gastric cancer. Dig Dis Sci. 2005;50 Suppl 1:S39-S44. [PMID: 16184420 DOI: 10.1007/s10620-005-2805-4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
16 Shao YJ, Chan T, Tsai K, Wu S. Association between proton pump inhibitors and the risk of hepatocellular carcinoma. Aliment Pharmacol Ther 2018;48:460-8. [DOI: 10.1111/apt.14835] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
17 Soykan I, Yakut M, Keskin O, Bektaş M. Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion. 2012;86:20-26. [PMID: 22710370 DOI: 10.1159/000338295] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 2.4] [Reference Citation Analysis]
18 Ali T, Roberts DN, Tierney WM. Long-term safety concerns with proton pump inhibitors. Am J Med. 2009;122:896-903. [PMID: 19786155 DOI: 10.1016/j.amjmed.2009.04.014] [Cited by in Crossref: 114] [Cited by in F6Publishing: 93] [Article Influence: 8.8] [Reference Citation Analysis]
19 Budzyński J, Kłopocka M, Bujak R, Swiatkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 2004;16:451-7. [PMID: 15097036 DOI: 10.1097/00042737-200405000-00003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 0.6] [Reference Citation Analysis]
20 Sato Y, Iwafuchi M, Ueki J, Yoshimura A, Mochizuki T, Motoyama H, Sugimura K, Honma T, Narisawa R, Ichida T, Asakura H, Van Thiel DH. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection. Dig Dis Sci. 2002;47:579-585. [PMID: 11911346 DOI: 10.1023/a:1017972204219] [Cited by in Crossref: 35] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
21 Lodato F, Azzaroli F, Turco L, Mazzella N, Buonfiglioli F, Zoli M, Mazzella G. Adverse effects of proton pump inhibitors. Best Pract Res Clin Gastroenterol. 2010;24:193-201. [PMID: 20227032 DOI: 10.1016/j.bpg.2009.11.004] [Cited by in Crossref: 55] [Cited by in F6Publishing: 43] [Article Influence: 4.6] [Reference Citation Analysis]
22 Sheen E, Triadafilopoulos G. Adverse effects of long-term proton pump inhibitor therapy. Dig Dis Sci. 2011;56:931-950. [PMID: 21365243 DOI: 10.1007/s10620-010-1560-3] [Cited by in Crossref: 187] [Cited by in F6Publishing: 167] [Article Influence: 17.0] [Reference Citation Analysis]
23 Kuipers EJ, Nelis GF, Klinkenberg-Knol EC, Snel P, Goldfain D, Kolkman JJ, Festen HP, Dent J, Zeitoun P, Havu N, Lamm M, Walan A. Cure of Helicobacter pylori infection in patients with reflux oesophagitis treated with long term omeprazole reverses gastritis without exacerbation of reflux disease: results of a randomised controlled trial. Gut 2004;53:12-20. [PMID: 14684569 DOI: 10.1136/gut.53.1.12] [Cited by in Crossref: 141] [Cited by in F6Publishing: 126] [Article Influence: 7.8] [Reference Citation Analysis]
24 Takaishi S, Cui G, Frederick DM, Carlson JE, Houghton J, Varro A, Dockray GJ, Ge Z, Whary MT, Rogers AB. Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer. Gastroenterology. 2005;128:1965-1983. [PMID: 15940630 DOI: 10.1053/j.gastro.2005.03.027] [Cited by in Crossref: 72] [Cited by in F6Publishing: 72] [Article Influence: 4.2] [Reference Citation Analysis]
25 Budzyński J, Kłopocka M. Brain-gut axis in the pathogenesis of Helicobacter pylori infection. World J Gastroenterol 2014; 20(18): 5212-5225 [PMID: 24833851 DOI: 10.3748/wjg.v20.i18.5212] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 5.4] [Reference Citation Analysis]
26 Lundell L, Vieth M, Gibson F, Nagy P, Kahrilas PJ. Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther. 2015;42:649-663. [PMID: 26177572 DOI: 10.1111/apt.13324] [Cited by in Crossref: 97] [Cited by in F6Publishing: 90] [Article Influence: 13.9] [Reference Citation Analysis]
27 Bardhan KD, Bishop AE, Polak JM, Romanska HM, Rowland A, Thompson M, Morris P, Schaefer-Preuss S, Luehmann R, McCaldin B. Pantoprazole in severe acid-peptic disease: the effectiveness and safety of 5 years' continuous treatment. Dig Liver Dis. 2005;37:10-22. [PMID: 15702854 DOI: 10.1016/j.dld.2004.05.015] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.9] [Reference Citation Analysis]
28 Waldum H, Fossmark R. Gastritis, Gastric Polyps and Gastric Cancer. Int J Mol Sci 2021;22:6548. [PMID: 34207192 DOI: 10.3390/ijms22126548] [Reference Citation Analysis]
29 Kuipers EJ. Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes? Basic Clin Pharmacol Toxicol 2006;99:187-94. [PMID: 16930292 DOI: 10.1111/j.1742-7843.2006.pto_478.x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
30 Kuipers EJ, Grool TA. The dynamics of gastritis. Curr Gastroenterol Rep 2001;3:509-15. [DOI: 10.1007/s11894-001-0072-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
31 Cipolletta L, Rotondano G, Dughera L, Repici A, Bianco MA, De Angelis C, Vingiani AM, Battaglia E. Delivery of radiofrequency energy to the gastroesophageal junction (Stretta procedure) for the treatment of gastroesophageal reflux disease. Surg Endosc 2005;19:849-53. [DOI: 10.1007/s00464-004-2169-4] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 1.7] [Reference Citation Analysis]
32 van Soest EM, van Rossum LG, Dieleman JP, van Oijen MG, Siersema PD, Sturkenboom MC, Kuipers EJ. Proton pump inhibitors and the risk of colorectal cancer. Am J Gastroenterol. 2008;103:966-973. [PMID: 18070237 DOI: 10.1111/j.1572-0241.2007.01665.x] [Cited by in Crossref: 48] [Cited by in F6Publishing: 47] [Article Influence: 3.2] [Reference Citation Analysis]
33 Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J. The stomach in health and disease. Gut. 2015;64:1650-1668. [PMID: 26342014 DOI: 10.1136/gutjnl-2014-307595] [Cited by in Crossref: 149] [Cited by in F6Publishing: 127] [Article Influence: 21.3] [Reference Citation Analysis]
34 Meuwissen SG, Craanen ME, Kuipers EJ. Gastric mucosal morphological consequences of acid suppression: a balanced view.Best Pract Res Clin Gastroenterol. 2001;15:497-510. [PMID: 11403542 DOI: 10.1053/bega.2001.0189] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
35 Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review. Dig Dis Sci 2010;55:2431-40. [PMID: 20012198 DOI: 10.1007/s10620-009-1076-x] [Cited by in Crossref: 70] [Cited by in F6Publishing: 63] [Article Influence: 5.4] [Reference Citation Analysis]